Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.

Lopez-Aladid, RubenGuiu, AlbaMosquera, Maria MarLopez-Medrano, FranciscoCofan, FredericLinares, LauraTorre-Cisneros, JulianVidal, ElisaMoreno, AsuncionAguado, Jose MariaCordero, ElisaMartin-Gandul, CeciliaCarratala, JordiSabe, NuriaNiubo, JordiCervera, CarlosCapon, AliciaCervilla, AnnaSantos, MartaBodro, MartaMuñoz, PatriciaFariñas, Maria CarmenAntón, AndresAranzamendi, MaitaneMontejo, MiguelPerez-Romero, PilarLen, OscarMarcos, Maria Angeles2023-01-252023-01-252019-05-07López-Aladid R, Guiu A, Mosquera MM, López-Medrano F, Cofán F, Linares L, et al. Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing. PLoS One. 2019 Jul 18;14(7):e0219701http://hdl.handle.net/10668/14252The aim of this study was to identify CMV drug resistance mutations (DRM) in solid organ transplant (SOT) recipients with suspected resistance comparing next-generation sequencing (NGS) with Sanger sequencing and assessing risk factors and the clinical impact of resistance. Using Sanger sequencing as the reference method, we prospectively assessed the ability of NGS to detect CMV DRM in the UL97 and UL54 genes in a nationwide observational study from September 2013 to August 2016. Among 44 patients recruited, 14 DRM were detected by Sanger in 12 patients (27%) and 20 DRM were detected by NGS, in 16 (36%). NGS confirmed all the DRM detected by Sanger. The additional six mutations detected by NGS were present in NGS showed a higher yield than Sanger sequencing for detecting CMV resistance mutations in SOT recipients. The presence of DRM detected by NGS was independently associated with longer antiviral treatment.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/CytomegalovirusDrug Resistance, ViralFemaleGenes, ViralFarmacorresistencia viralHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMutationTransplant RecipientsImprovement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.research article31318908open accessMutaciónSecuenciación de nucleótidos de alto rendimientoReceptores de trasplantes10.1371/journal.pone.02197011932-6203PMC6638921https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0219701&type=printablehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638921/pdf